Mymetics strengthens virosome vaccine platform
Epalinges, Switzerland, March 10, 2014
Mymetics announced today that it has secured and further strengthened its know-how and leadership in the research and development of virosome based vaccines as well in manufacturing and IP.
|Media Name||Media Type||Description||Download|
|140310 Mymetics Press release virosome know-how and IP_final||Download|